Levetiracetam Dealers in Dandi Road, Surat

Levetiracetam has been approved in the United States as add-on treatment for partial (focal), myoclonic, and tonic-clonic seizures.Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case of partial seizures, or as an adjunctive therapy for partial, myoclonic, and tonic-clonic seizures.Levetiracetam has been shown to reduce partial (focal) seizures by 50% or more as an add-on medication.It is also used in veterinary medicine for similar purposes.

• Country of Origin: India
• CAS No.: 102767-28-2
• Groups: Anti-epileptic
• IUPAC ID: (S)-2-(2-oxopyrrolidin-1-yl)butanamide
• Molar mass: 170.209 g/mol
• Soluble in: Water
• Metabolism: Enzymatic hydrolysis of acetamide group
• Elimination half-life: 6–8 hrs

·         Product Name : LEVETIRACETAM ·         Product Code: ATM023LEV ·         Grade :  BP / USP ·         Therapeutic Category : ANTIEPILEPTIC ·         CAS No : 102767-28-2 ·         COA : Available ·         MSDS : Available